Antimicrobial Agents and Chemotherapy · 2012 · 29 citations · 19 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyMedical MicrobiologyMusculoskeletal InfectionAntibacterial PharmacologyAntibacterial PharmacotherapyAntimicrobial PharmacodynamicsBone InfectionsOsteomyelitisPharmacokinetics Of AntimicrobialsBactericidal AgentsDaptomycin ResistanceMechanistic Pharmacokinetic-pharmacodynamic ModelsMicrobiology Of OsteomyelitisOsteomyelitis Antibiotic ManagementResistance In Clinical IsolatesTrimethoprim-sulfamethoxazole TherapyVertebral Osteomyelitis Antibiotic Therapy
We report two cases of daptomycin (DAP)-nonsusceptible (DNS) vancomycin-intermediate Staphylococcus aureus (VISA) vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole. Both patients responded rapidly and favorably to this combination. The clinical isolates from the two patients were tested post hoc in an in vitro pharmacokinetic/pharmacodynamic (PK/PD) model to confirm the bactericidal activity and enhancement of daptomycin and trimethoprim-sulfamethoxazole. The combination of high-dose daptomycin and trimethoprim-sulfamethoxazole should be explored further for the treatment of DNS VISA strains.
19
Benjamin P. Howden, Peter Ward, Patrick G. P. Charles et al. · Clinical Infectious Diseases · 2004 · 485 citations
Mark Benvenuto, David P. Benziger, Sara Yankelev et al. · Antimicrobial Agents and Chemotherapy · 2006 · 322 citations · Full text
Sujata M. Bhavnani, Christopher M. Rubino, Paul G. Ambrose et al. · Clinical Infectious Diseases · 2010 · 276 citations · Full text